SPP1 and heart failure: Our findings align with Li et al.’s report that OPN signaling inhibition can partially reverse heart failure and improve cardiac function (45), establishing the OPN-ERS axis in RVF pathogenesis and providing insights for developing targeted therapeutic strategies.